Pricing Log in Create free account
Friday 6 November 2026 Export CRL’s income statement to Excel — free account

Charles River Laboratories International, Inc.

CRL Healthcare Diagnostics & Research

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024.

Revenue
−2.20%
EPS
+530.3%
Free cash flow
+16.3%
Total debt
+11.8%

Quarter to September 2026, against a year earlier

313.98 12.31 −3.77%
Market cap
$14.9B
P/E
300×
Fwd P/E
89.2×
Dividend yield
—
F-score
5/9
Altman Z
2.40
Beneish M
−3.11
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Charles River Laboratories International, Inc. (CRL) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Charles River Laboratories International, Inc. (CRL) trades at a P/S ratio of 3.8×. Over the past ten years it has ranged from 1.3× (April 2025) to 7.0× (September 2021); the current reading is higher than 85% of that period. That is below the Diagnostics & Research industry median of 4.2× and above the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.5× 5.14%
FY2024 2.3× (19.41%)
FY2023 2.9× 4.12%
FY2022 2.8× (47.86%)
FY2021 5.4× 26.42%
FY2020 4.2× 49.10%
FY2019 2.8× 18.59%
FY2018 2.4× (15.33%)
FY2017 2.8× 32.18%
FY2016 2.1× (21.95%)

Quarterly newest first

Period P/S ratio Change
Sep 2026 3.5× 30.21%
Jun 2026 2.7× 29.88%
Mar 2026 2.1× (14.84%)
Dec 2025 2.5× 28.67%
43 more quarters

Against its own ten years

Low 1.3× High 7.0×
Ten-year median 2.7×
Current reading's percentile 84

P/S ratio against peers

Company P/S ratio
ICLR ICON PLC compare 1.9×
LH Labcorp Holdings Inc. compare 2.0×
DGX Quest Diagnostics Incorporated compare 2.4×
CRL Charles River Laboratories International, Inc. 3.8×
QGEN QIAGEN N.V. compare 5.0×
RVTY Revvity Inc. compare 5.7×
MEDP Medpace Holdings, Inc. compare 6.2×
ILMN Illumina, Inc. compare 7.0×
GH Guardant Health, Inc. compare 16.2×
Diagnostics & Research industry median 4.2×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on CRL